Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Cruveilhier-Baumgarten Syndrome

glucose, (beta-d)-isomer has been researched along with Cruveilhier-Baumgarten Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Brand, S; Gerbes, AL; Gmelin, L; Göke, B; Pfeiler, S; Schewe, J; Steib, CJ1
Garcia-Tsao, G; Saffo, S; Taddei, T1

Other Studies

2 other study(ies) available for glucose, (beta-d)-isomer and Cruveilhier-Baumgarten Syndrome

ArticleYear
Functional relevance of the cannabinoid receptor 2 - heme oxygenase pathway: a novel target for the attenuation of portal hypertension.
    Life sciences, 2013, Oct-11, Volume: 93, Issue:16

    Topics: Animals; Anti-Inflammatory Agents; Cannabinoid Receptor Agonists; Cannabinoids; Heme Oxygenase (Decyclizing); Hypertension, Portal; Indenes; Kupffer Cells; Lipopolysaccharides; Male; Molecular Targeted Therapy; Portal Pressure; PPAR alpha; Pyrazoles; Rats; Receptor, Cannabinoid, CB2; Thromboxane B2; Zymosan

2013
SGLT2 inhibitors in patients with cirrhosis and diabetes mellitus: A tertiary center cohort study and insights about a potential therapeutic target for portal hypertension.
    Journal of diabetes, 2021, Volume: 13, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Female; Glucosides; Glycated Hemoglobin; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Outcome Assessment, Health Care; Polyuria; Sodium-Glucose Transporter 2 Inhibitors; Tertiary Care Centers; Urinary Tract Infections; Young Adult

2021